Journal article 636 views
Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways
Hiu-Fung Yuen,
Ka-Kui Chan,
Claire Grills,
James Murray ,
Angela Platt-Higgins,
Osama Sharaf Eldin,
Ken O'Byrne,
Pasi Janne,
Dean A. Fennell,
Patrick G. Johnston,
Philip S. Rudland,
Mohamed El-Tanani
Clinical Cancer Research, Volume: 18, Issue: 2, Pages: 380 - 391
Swansea University Author: James Murray
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1158/1078-0432.ccr-11-2035
Abstract
Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways
Published in: | Clinical Cancer Research |
---|---|
ISSN: | 1078-0432 1557-3265 |
Published: |
American Association for Cancer Research (AACR)
2012
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa56416 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
first_indexed |
2021-03-23T15:47:18Z |
---|---|
last_indexed |
2021-03-24T04:22:07Z |
id |
cronfa56416 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2021-03-23T15:48:13.1718004</datestamp><bib-version>v2</bib-version><id>56416</id><entry>2021-03-11</entry><title>Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways</title><swanseaauthors><author><sid>12d0a585fcfe66f83c4c21c6bca3197b</sid><ORCID>0000-0002-6928-2347</ORCID><firstname>James</firstname><surname>Murray</surname><name>James Murray</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2021-03-11</date><deptcode>BMS</deptcode><abstract/><type>Journal Article</type><journal>Clinical Cancer Research</journal><volume>18</volume><journalNumber>2</journalNumber><paginationStart>380</paginationStart><paginationEnd>391</paginationEnd><publisher>American Association for Cancer Research (AACR)</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>1078-0432</issnPrint><issnElectronic>1557-3265</issnElectronic><keywords/><publishedDay>15</publishedDay><publishedMonth>1</publishedMonth><publishedYear>2012</publishedYear><publishedDate>2012-01-15</publishedDate><doi>10.1158/1078-0432.ccr-11-2035</doi><url/><notes/><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2021-03-23T15:48:13.1718004</lastEdited><Created>2021-03-11T10:12:46.9571414</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Hiu-Fung</firstname><surname>Yuen</surname><order>1</order></author><author><firstname>Ka-Kui</firstname><surname>Chan</surname><order>2</order></author><author><firstname>Claire</firstname><surname>Grills</surname><order>3</order></author><author><firstname>James</firstname><surname>Murray</surname><orcid>0000-0002-6928-2347</orcid><order>4</order></author><author><firstname>Angela</firstname><surname>Platt-Higgins</surname><order>5</order></author><author><firstname>Osama Sharaf</firstname><surname>Eldin</surname><order>6</order></author><author><firstname>Ken</firstname><surname>O'Byrne</surname><order>7</order></author><author><firstname>Pasi</firstname><surname>Janne</surname><order>8</order></author><author><firstname>Dean A.</firstname><surname>Fennell</surname><order>9</order></author><author><firstname>Patrick G.</firstname><surname>Johnston</surname><order>10</order></author><author><firstname>Philip S.</firstname><surname>Rudland</surname><order>11</order></author><author><firstname>Mohamed</firstname><surname>El-Tanani</surname><order>12</order></author></authors><documents/><OutputDurs/></rfc1807> |
spelling |
2021-03-23T15:48:13.1718004 v2 56416 2021-03-11 Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways 12d0a585fcfe66f83c4c21c6bca3197b 0000-0002-6928-2347 James Murray James Murray true false 2021-03-11 BMS Journal Article Clinical Cancer Research 18 2 380 391 American Association for Cancer Research (AACR) 1078-0432 1557-3265 15 1 2012 2012-01-15 10.1158/1078-0432.ccr-11-2035 COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University 2021-03-23T15:48:13.1718004 2021-03-11T10:12:46.9571414 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Hiu-Fung Yuen 1 Ka-Kui Chan 2 Claire Grills 3 James Murray 0000-0002-6928-2347 4 Angela Platt-Higgins 5 Osama Sharaf Eldin 6 Ken O'Byrne 7 Pasi Janne 8 Dean A. Fennell 9 Patrick G. Johnston 10 Philip S. Rudland 11 Mohamed El-Tanani 12 |
title |
Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways |
spellingShingle |
Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways James Murray |
title_short |
Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways |
title_full |
Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways |
title_fullStr |
Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways |
title_full_unstemmed |
Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways |
title_sort |
Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways |
author_id_str_mv |
12d0a585fcfe66f83c4c21c6bca3197b |
author_id_fullname_str_mv |
12d0a585fcfe66f83c4c21c6bca3197b_***_James Murray |
author |
James Murray |
author2 |
Hiu-Fung Yuen Ka-Kui Chan Claire Grills James Murray Angela Platt-Higgins Osama Sharaf Eldin Ken O'Byrne Pasi Janne Dean A. Fennell Patrick G. Johnston Philip S. Rudland Mohamed El-Tanani |
format |
Journal article |
container_title |
Clinical Cancer Research |
container_volume |
18 |
container_issue |
2 |
container_start_page |
380 |
publishDate |
2012 |
institution |
Swansea University |
issn |
1078-0432 1557-3265 |
doi_str_mv |
10.1158/1078-0432.ccr-11-2035 |
publisher |
American Association for Cancer Research (AACR) |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
document_store_str |
0 |
active_str |
0 |
published_date |
2012-01-15T04:11:21Z |
_version_ |
1763753781124661248 |
score |
11.037319 |